135 related articles for article (PubMed ID: 28428054)
1. Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer.
Liu X; Gao X; Zheng S; Wang B; Li Y; Zhao C; Muftuoglu Y; Chen S; Li Y; Yao H; Sun H; Mao Q; You C; Guo G; Wei Y
Nanomedicine; 2017 Aug; 13(6):1993-2004. PubMed ID: 28428054
[TBL] [Abstract][Full Text] [Related]
2. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system.
Liu X; Li Y; Sun X; Muftuoglu Y; Wang B; Yu T; Hu Y; Ma L; Xiang M; Guo G; You C; Gao X; Wei Y
Theranostics; 2018; 8(13):3490-3503. PubMed ID: 30026861
[No Abstract] [Full Text] [Related]
3. Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles as an Efficient Colon Cancer Immunogene Therapy.
Wang K; Gao Y; Wu S; Zhang J; Zhu M; Chen X; Fu X; Duan X; Men K
Int J Nanomedicine; 2024; 19():4779-4801. PubMed ID: 38828196
[TBL] [Abstract][Full Text] [Related]
4. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL
Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055
[TBL] [Abstract][Full Text] [Related]
5. Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy.
Luo M; Liang X; Luo ST; Wei XW; Liu T; Ren J; Ma CC; Yang YH; Wang BL; Liu L; Song XR; He ZY; Wei YQ
J Biomed Nanotechnol; 2015 Nov; 11(11):2011-23. PubMed ID: 26554159
[TBL] [Abstract][Full Text] [Related]
6. Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex.
Wang X; Hua Y; Xu G; Deng S; Yang D; Gao X
Int J Nanomedicine; 2019; 14():2637-2653. PubMed ID: 31043779
[TBL] [Abstract][Full Text] [Related]
7. Local and Systemic Delivery of Interleukin-12 Gene by Cationic Micelles for Cancer Immunogene Therapy.
Men K; Huang R; Zhang X; Zhang R; Zhang Y; He M; Tong R; Yang L; Wei Y; Duan X
J Biomed Nanotechnol; 2018 Oct; 14(10):1719-1730. PubMed ID: 30041719
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
[TBL] [Abstract][Full Text] [Related]
9. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles.
Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488
[TBL] [Abstract][Full Text] [Related]
10. Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1.
Zhou P; Cao Y; Liu X; Yu T; Xu Q; You C; Gao X; Wei Y
Int J Nanomedicine; 2018; 13():4781-4793. PubMed ID: 30214189
[TBL] [Abstract][Full Text] [Related]
11. Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer.
Tada H; Kishida T; Fujiwara H; Kosuga T; Konishi H; Komatsu S; Shiozaki A; Ichikawa D; Okamoto K; Otsuji E; Mazda O
Immunotherapy; 2017 Mar; 9(3):239-248. PubMed ID: 28231722
[TBL] [Abstract][Full Text] [Related]
12. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy.
Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X
Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664
[TBL] [Abstract][Full Text] [Related]
13. Cationic Polyphosphazene Vesicles for Cancer Immunotherapy by Efficient in Vivo Cytokine IL-12 Plasmid Delivery.
Gao M; Zhu X; Wu L; Qiu L
Biomacromolecules; 2016 Jun; 17(6):2199-209. PubMed ID: 27192398
[TBL] [Abstract][Full Text] [Related]
14. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract][Full Text] [Related]
15. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
[TBL] [Abstract][Full Text] [Related]
16. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
[TBL] [Abstract][Full Text] [Related]
18. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells.
Kim TH; Jin H; Kim HW; Cho MH; Cho CS
Mol Cancer Ther; 2006 Jul; 5(7):1723-32. PubMed ID: 16891458
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of colon tumor growth by IL-15 immunogene therapy.
He X; Li W; Wang Y; Hou L; Zhu L
Mol Med Rep; 2012 Jan; 5(1):96-102. PubMed ID: 21956355
[TBL] [Abstract][Full Text] [Related]
20. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
